Skip to Content

Skyrizi Prices, Coupons and Patient Assistance Programs

Skyrizi (risankizumab) is a member of the interleukin inhibitors drug class and is commonly used for Plaque Psoriasis and Psoriasis.

Skyrizi Prices

This Skyrizi price guide is based on using the discount card which is accepted at most U.S. pharmacies. The cost for Skyrizi subcutaneous kit (75 mg/0.83 mL) is around $16,548 for a supply of 1 kits, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Subcutaneous Kit

75 mg/0.83 mL Skyrizi subcutaneous kit
from $16,548.03 for 1 kit
Quantity Per unit Price
1 $16,548.03 $16,548.03

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee. Printable Discount Card

Print Now

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Skyrizi Coupons and Rebates

Skyrizi offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Applies to:Skyrizi
Number of uses:Per prescription until program expires

Patient Assistance Programs for Skyrizi

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:

  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Skyrizi (risankizumab-rzaa) Injection

Provider: myAbbVie Assist for Skyrizi

Elligibility requirements:

  1. Must be uninsured or underinsured
  2. At or below 600% of FPL
  3. FDA-approved diagnosis
  4. Must reside in the US and be under the direct care of a US physician
  5. Any patient who requires the medication and are in need should call the company. Eligibility determined on a case-by-case basis. Patients with prescription drug coverage may be eligible on exception basis. Contact program for details.

Applicable drugs:

  • Skyrizi (risankizumab-rzaa) Injection

Provider: Skyrizi Complete Sharps Disposal Program

Elligibility requirements:

  1. Not specified
  2. Not Required
  3. Not specified
  4. The patient must also be residing in the US.
  5. Patient enrolls to receive a free sharps container.

Applicable drugs:

  • Skyrizi (container for skyrizi) Disposal Container